BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
ID: NIH-CC-OPC-25-000002Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/7bb73893aeca4defad0eaf71dfec7cc7/view
Timeline
    Description

    The National Institutes of Health (NIH) is seeking qualified contractors to provide leasing, consumables, and maintenance services for the BD FACSLyric™ 3L10C system, as part of a sources sought announcement. The procurement aims to ensure the continued operation of critical laboratory equipment used for immunology flow cytometry, which is essential for delivering over one million test results annually for patient care and research. This opportunity emphasizes the need for proprietary reagents and robust support from the manufacturer, highlighting the importance of consistent and reliable testing in a clinical research environment. Interested parties must submit their responses by 12:00 PM Eastern Standard Time on October 23, 2024, to the primary contact, Kimala Winfield, at kimala.winfield@nih.gov.

    Point(s) of Contact
    Kimala Winfield
    (301) 496-7015
    kimala.winfield@nih.gov
    Malinda Dehner
    (301) 594-6320
    dehnerm@cc.nih.gov
    Files
    Title
    Posted
    List of Equipment - Attachment 1.docx
    The document outlines a detailed list of equipment and supplies associated with a federal government contract, primarily focused on laboratory instruments and related technology. Key items include various instruments from BD, such as the BD FACSLyric™ 3L10C Instrument and BD FACSDuet™ Premium Sample Prep, along with their respective prices totaling over $500,000. Additional items include label printers, management software, and computer peripherals necessary for operational efficiency in a laboratory setting. The equipment is predominantly intended for use in diagnostic and research applications, ensuring compliance with U.S. Food and Drug Administration (FDA) regulations. The list appears to support federal grants and RFPs related to health care or research sectors, suggesting the need for advanced diagnostic capabilities and efficient laboratory workflows. The structured presentation of items includes their model numbers, quantities, and costs, effectively serving as a procurement guide for government agencies focused on scientific research and health diagnostics. Overall, this document underscores the importance of investing in sophisticated laboratory equipment to enhance research capabilities and diagnostic accuracy within federal initiatives.
    List of Supplies - Attachment 2.docx
    The document is a detailed inventory list of materials and supplies, primarily focused on immunological and biochemical analysis products. It includes specific catalog numbers, descriptions of the materials, and quantities required for procurement. The items listed comprise a range of reagents and kits, such as antibodies (e.g., various CD markers), lysing solutions, and assay controls, necessary for laboratory research or clinical applications. Additionally, each product is categorized based on its intended use, identified in terms of In Vitro Diagnostic (IVD) or Research Use Only/Good Manufacturing Practice (RUO/GMP) status. This inventory serves as part of a larger government Request for Proposals (RFPs) process, evidencing the need for these supplies to support federal, state, and local government objectives in health and research initiatives. The structured format promotes clarity in procurement efforts while ensuring compliance with appropriate regulatory standards.
    Statement of Work.pdf
    The document outlines a Reagent Rental Agreement for the Clinical Center at the National Institutes of Health (NIH), focusing on the acquisition of essential laboratory equipment and reagents for immunology flow cytometry. The agreement spans an initial year with four optional extension years, beginning January 1, 2025. The goal is to provide critical diagnostic and treatment information to healthcare professionals, enhancing patient outcomes through advanced cellular analysis. The proposed equipment includes various BD instruments and associated reagents, with specifications demanding robust support and a manufacturer’s warranty. The background emphasizes NIH's role as a clinical research hospital for human research protocols, highlighting the importance of using BD’s reagents for reliable test consistency. A comprehensive list of reagents is presented, supporting analyses for patient care and research. Overall, the document serves as a formal Request for Proposal (RFP) to facilitate the efficient procurement of necessary laboratory resources, ensuring the Clinical Center’s operational needs remain met while contributing to ongoing research and clinical care advancements.
    Similar Opportunities
    J--Fortessa Flow Cytometer Analyzer Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking maintenance services for the Fortessa Flow Cytometer Analyzer. The procurement aims to ensure the proper functioning and reliability of this critical laboratory equipment, which is essential for various biomedical research applications. The maintenance services will fall under the NAICS code 811210, focusing on electronic and precision equipment repair and maintenance, and will be classified under PSC code J066 for the maintenance and repair of laboratory instruments. Interested vendors can reach out to Noelle Decenzo at noelle.decenzo@nih.gov or call 301-402-5571 for further details regarding this presolicitation opportunity.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    RENEWAL SERVICE AGREEMENT CYTEK AURORA 5 LASER W/LOADER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for a renewal service agreement for the Cytek Aurora 5 Laser Cytometer, including its sample loader and associated computer workstation. The procurement aims to secure a comprehensive maintenance service contract that covers parts and service for the equipment, ensuring its operational efficiency for the Laboratory of Parasitic Diseases (LPD) at NIH, which conducts critical research on parasitic and bacterial diseases. This service is vital for maintaining the functionality of the cytometer, which plays a crucial role in the laboratory's research activities. Interested vendors must submit their quotes by December 30, 2024, at 12:00 PM EST, and can direct inquiries to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    Werfen USA LLC Various Consumables and lease of two ACL Top 750 Instruments for the Department of Laboratory Medicine at the NIH Clinical Center
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a firm fixed price purchase order to Werfen USA LLC for various consumables and the lease of two ACL Top 750 instruments for the Department of Laboratory Medicine at the NIH Clinical Center. This acquisition aims to extend the lease of the ACL TOP 750 analyzers, which are critical for conducting routine and specialized coagulation tests in mid to high-volume clinical laboratories, enhancing lab efficiency and result reliability. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by December 27, 2024, 6:30 AM EST, with the total contract value not exceeding $250,000, as this procurement is being conducted under Simplified Acquisition Procedures.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Leica Microsystems Inc. for a 12-month renewal Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444), with two optional one-year extensions. The procurement aims to secure a comprehensive maintenance agreement that includes unlimited service visits by trained engineers, OEM replacement parts, annual planned maintenance, and access to expert support, ensuring the microscope operates at optimal performance levels. This equipment is crucial for research and diagnostics in the field of allergy and infectious diseases, highlighting the importance of maintaining its functionality. Interested vendors must submit capability statements by 10:00 AM EST on December 30, 2024, through the NIAID electronic Simplified Acquisition Submission System (eSASS), with all required documentation to be included for consideration.
    NOTICE OF INTENT FOR iSEQ 100 ADVANCE, Mi SEQ, AND NEXT SEQ 2000 SILVER SUPPORT PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Illumina for a Silver Support Plan covering specific laboratory equipment, including the Nextseq 2000 and MiSeq systems. This support plan includes comprehensive services such as full coverage for parts, labor, and travel, OEM parts and service, reagent replacement due to equipment failures, scheduled maintenance visits, remote technical support, and timely on-site response, all over a 12-month term billed quarterly. The procurement is critical for maintaining the operational efficiency of NIAID's laboratory capabilities, ensuring that essential equipment remains functional and supported. Interested vendors must submit their responses via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 23, 2024, at 10:00 AM EST, and should direct any inquiries to Leah Hinson at leah.hinson@nih.gov.